Accedi a banche dati online | Convegnodetail
Anteprima di stampa
 
 

Neuropathic Pain Therapeutics Summit

Evvnt Promotion / evvnt
-
24.08.2021 - 25.08.2021  Online
Time: 08:00 to 17:00
 
Temi della conferenza
The First Industry-Dedicated Conference Focused on Accelerating Novel Neuropathic Pain Therapeutics into the Clinic.

The opioid crisis rages on unabated. Meanwhile, the global population continues to age, creating an enormous need for next-generation neuropathic pain treatment and management approaches. This has stimulated a renewed sense of urgency to discover, translate and accelerate non-addictive and clinically effective pain relief therapeutics into the clinic and to patients in pain.
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/768538-0?pid=4832

Speakers: Steven Fox, Chairman and Founder, Akelos, Inc, Irving Sucholeiki, President and Chief Executive Officer, Aquilus Pharmaceuticals, Gary J. Bennett, Co-Founder, BioIntervene Inc., and more.
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/768538-2?pid=4832
Mr. Customer Service
 
Categorie
Medicina General
Lingua
Inglese
Quote del Congresso
Conference - Industry - Early Bird Available: USD 1199.00, Conference - Academic - Early Bird Available: USD 899.00
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

Charité International AcademyHelix - Forschung & Beratung WienSwiss Tropical and Public Health InstituteÄrzte der WeltÖsterreichische Gesellschaft für Public HealthCenter of ExcellenceOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation newTree